Understanding Parkinson's Disease: Mechanisms of Action of DJ-1

Parkinson’s disease (PD) is the most common movement neurodegenerative disease affecting approximately 1% of the population over 60. Though originally thought to be sporadic in nature, a genetic component is increasingly being linked to the disease. Of these genes, mutations in DJ-1 (PARK7) cause ea...

Full description

Bibliographic Details
Main Author: Rousseaux, Maxime
Language:en
Published: 2012
Subjects:
ROS
Online Access:http://hdl.handle.net/10393/22904
id ndltd-LACETR-oai-collectionscanada.gc.ca-OOU-OLD.-22904
record_format oai_dc
spelling ndltd-LACETR-oai-collectionscanada.gc.ca-OOU-OLD.-229042013-04-05T03:21:10ZUnderstanding Parkinson's Disease: Mechanisms of Action of DJ-1Rousseaux, MaximeDJ-1Parkinson's diseaseROSAnimal modelsParkinson’s disease (PD) is the most common movement neurodegenerative disease affecting approximately 1% of the population over 60. Though originally thought to be sporadic in nature, a genetic component is increasingly being linked to the disease. Of these genes, mutations in DJ-1 (PARK7) cause early onset autosomal recessive PD. Initial workup of the DJ-1 protein has suggested that it may act in the cell by combatting oxidative stress though the mechanism by which it does so is unclear. Thus, though much work has attempted to elucidate a function at the biochemical, cellular and organismal level, the overt physiological role of DJ-1 remains elusive. In this dissertation, we explore the mechanisms through which DJ-1 confers neuroprotection, particularly in the case of oxidative stress insult. We demonstrate that DJ-1 acts through the pro-survival protein AKT to accomplish its neuroprotective function. Moreover, we note that DJ-1 likely serves its role as an antioxidant through the NRF2 master antioxidant regulator pathway a pathway that is, itself, likely to be regulated by AKT. Together, our results demonstrate that neuroprotection by DJ-1 is done through a signaling pathway involving both AKT and NRF2 and that disruption of the former in PD likely results in abolishing this signaling pathway. Finally, to generate a better animal model of PD, we demonstrate that backcrossing DJ-1 null mice - which originally did not demonstrate any gross histopathological or behavioral phenotypes – display unilateral dopaminergic degeneration that progresses to bilateral degeneration with aging, a feature reminiscent of classical PD progression. Collectively, this thesis takes a two-sided approach to address the biochemical and physiological functions of DJ-1 within the cell and the mouse in hopes of elucidating mechanisms of neuronal death to devise better translational therapies.2012-06-15T07:39:56Z2012-06-15T07:39:56Z20122012-06-15Thèse / Thesishttp://hdl.handle.net/10393/22904en
collection NDLTD
language en
sources NDLTD
topic DJ-1
Parkinson's disease
ROS
Animal models
spellingShingle DJ-1
Parkinson's disease
ROS
Animal models
Rousseaux, Maxime
Understanding Parkinson's Disease: Mechanisms of Action of DJ-1
description Parkinson’s disease (PD) is the most common movement neurodegenerative disease affecting approximately 1% of the population over 60. Though originally thought to be sporadic in nature, a genetic component is increasingly being linked to the disease. Of these genes, mutations in DJ-1 (PARK7) cause early onset autosomal recessive PD. Initial workup of the DJ-1 protein has suggested that it may act in the cell by combatting oxidative stress though the mechanism by which it does so is unclear. Thus, though much work has attempted to elucidate a function at the biochemical, cellular and organismal level, the overt physiological role of DJ-1 remains elusive. In this dissertation, we explore the mechanisms through which DJ-1 confers neuroprotection, particularly in the case of oxidative stress insult. We demonstrate that DJ-1 acts through the pro-survival protein AKT to accomplish its neuroprotective function. Moreover, we note that DJ-1 likely serves its role as an antioxidant through the NRF2 master antioxidant regulator pathway a pathway that is, itself, likely to be regulated by AKT. Together, our results demonstrate that neuroprotection by DJ-1 is done through a signaling pathway involving both AKT and NRF2 and that disruption of the former in PD likely results in abolishing this signaling pathway. Finally, to generate a better animal model of PD, we demonstrate that backcrossing DJ-1 null mice - which originally did not demonstrate any gross histopathological or behavioral phenotypes – display unilateral dopaminergic degeneration that progresses to bilateral degeneration with aging, a feature reminiscent of classical PD progression. Collectively, this thesis takes a two-sided approach to address the biochemical and physiological functions of DJ-1 within the cell and the mouse in hopes of elucidating mechanisms of neuronal death to devise better translational therapies.
author Rousseaux, Maxime
author_facet Rousseaux, Maxime
author_sort Rousseaux, Maxime
title Understanding Parkinson's Disease: Mechanisms of Action of DJ-1
title_short Understanding Parkinson's Disease: Mechanisms of Action of DJ-1
title_full Understanding Parkinson's Disease: Mechanisms of Action of DJ-1
title_fullStr Understanding Parkinson's Disease: Mechanisms of Action of DJ-1
title_full_unstemmed Understanding Parkinson's Disease: Mechanisms of Action of DJ-1
title_sort understanding parkinson's disease: mechanisms of action of dj-1
publishDate 2012
url http://hdl.handle.net/10393/22904
work_keys_str_mv AT rousseauxmaxime understandingparkinsonsdiseasemechanismsofactionofdj1
_version_ 1716579576541347840